Similarly, miR-218 was expressed highest in low-grade tumors (histologic grade 1 or 2), while EGFR was primarily expressed in high-grade breast cancer samples (histologic grade 3, Fig. 1D). This evidence concerns the gene EGFR and breast cancer.